Changes of sides at Takeda Italia. The company has announced the appointment of Chiara Giorgi in the role of gastroenterology business unit head e David Borrelliappointed Head of strategy & innovation/ Ns & vaccines and thus became part of the Takeda Italia leadership team.
This is, the company states in a note, a confirmation for both of the professionalism and value demonstrated in these years of work in the pharmaceutical sector and of the path undertaken in Takeda Italia.
The challenges of the coming months
With these two appointments, the company underlines, Takeda Italia is preparing to face the important challenges of the coming months. Chiara Giorgi will ensure a defined strategic direction for the gastroenterology team, contributing to the achievement of company objectives and always keeping patients’ needs at the centre.
“This new challenge, in one of the company’s therapeutic areas of excellence, will see me committed to promoting research into innovative solutions for gastrointestinal diseases, starting from listening to real treatment needs, while strengthening Takeda’s leadership in the Gi area”.
The Vision on Vaccines and Neuroscience
In parallel, the appointment of Davide Borrelli guarantees the necessary focus for the management of two innovative areas for Takeda, that of vaccines and that of neuroscience.
“Vaccines represent a dimension of global impact for Takeda, just as research and development in neuroscience is central to improving the treatment path and the unmet needs of patients – declared Davide Borrelli commenting on his new role – leading this business unit It is a privilege and a great responsibility for me. I am committed to leading this extraordinary team towards increasingly ambitious goals, through passion, determination and the support of increasingly cutting-edge technologies. A growth path that I am proud to undertake together with my colleagues in the Takeda Italia leadership team.”
Develop a robust pipeline
“At Takeda we are developing a solid pipeline for the future and these two appointments are a clear signal of our commitment to strengthen and make more strategic two key sectors for the company. I am convinced that the leadership of Chiara Giorgi and Davide Borrelli will significantly contribute to our goal of generating value for patients and maintaining Takeda as a point of reference in the pharmaceutical sector”, she wanted to comment. Anna Maria Bencinigeneral manager of Takeda Italia.
